Posts in: press clippings (2)

SynBioBeta: Successful pilot scale run
press clippings
SynBioBeta: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalabilityMarch 21, 2026
Business Insider
press clippings
Business Insider: eXoZymes announces validation milestone for its biomanufacturing platformMarch 20, 2026
USA Today: Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes’ Technology and Scalability
press clippings
USA Today: Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes’ Technology and ScalabilityMarch 20, 2026
GEN: eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical
press clippings
GEN: eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman ChemicalMarch 19, 2026
The Big Skinny: Lou Basenese states that eXoZymes is the BASF of 2026
investorpress clippingsvideo
The Big Skinny: Lou Basenese states that eXoZymes is the BASF of 2026February 16, 2026
Nasdaq's 'Amplify Spotlight'
heltzeninvestorpress clippingsvideo
Nasdaq: Michael B. Spector interviews CEO HeltzenFebruary 5, 2026
yahoo! finance
investorpress clippings
yahoo! finance: eXoZymes demonstrates end-to-end biomanufacturability of NCT, from reaction to high-purity isolated productJanuary 30, 2026
Capital Markets Advisor, Sanjeev Srivastava, interviewed by Maxine Hoover
investorpress clippingsvideo
Beryl Elites: Interview with Capital Markets Advisor, Sanjeev SrivastavaJanuary 8, 2026
CEO Heltzen interviewed by Maxine Hoover at the Beryl Elites’ Investment Conference in New York City
heltzeninvestorpress clippingsvideo
Beryl Elites: What is Artificial Evolution - an interview with CEO HeltzenJanuary 7, 2026
IBT: AI meets enzymes
investornutraceuticalsmedicinepress clippings
International Business Times: AI meets enzymes - eXoZymes enables high-yield production of compounds previously impossible to makeDecember 17, 2025
Previous page
Page 2 of 5
Next page